These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer. Liu L; Long M; Su S; Wang L; Liu J PeerJ; 2024; 12():e16747. PubMed ID: 38223758 [TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756 [TBL] [Abstract][Full Text] [Related]
5. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1 Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer. Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy. Bai YG; Gao GX; Zhang H; Zhang S; Liu YH; Duan XN; Xu L Chin Med J (Engl); 2020 Mar; 133(5):552-560. PubMed ID: 32044815 [TBL] [Abstract][Full Text] [Related]
8. Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery. Mori K; Toiyama Y; Saigusa S; Fujikawa H; Hiro J; Kobayashi M; Ohi M; Araki T; Inoue Y; Tanaka K; Mohri Y; Kusunoki M Dig Dis Sci; 2015 Aug; 60(8):2477-87. PubMed ID: 25840921 [TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of CD4+ and CD8+ tumor-infiltrating lymphocytes in patients with colorectal cancer. Tao Y; Xie Y Acta Chir Belg; 2024 Feb; 124(1):35-40. PubMed ID: 36780176 [TBL] [Abstract][Full Text] [Related]
10. Differential gene expression of tumor-infiltrating CD8 Saleh R; Sasidharan Nair V; Toor SM; Taha RZ; Murshed K; Al-Dhaheri M; Khawar M; Petkar MA; Abu Nada M; Al-Ejeh F; Elkord E J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948653 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer. Zou Q; Wang X; Ren D; Hu B; Tang G; Zhang Y; Huang M; Pai RK; Buchanan DD; Win AK; Newcomb PA; Grady WM; Yu H; Luo Y J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34548385 [TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer. Qin M; Chen G; Hou J; Wang L; Wang Q; Wang L; Jiang D; Hu Y; Xie B; Chen J; Wei H; Xu G Bioengineered; 2022 Jun; 13(6):14872-14888. PubMed ID: 36633318 [TBL] [Abstract][Full Text] [Related]
14. ITGAE Defines CD8+ Tumor-Infiltrating Lymphocytes Predicting a better Prognostic Survival in Colorectal Cancer. Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ EBioMedicine; 2018 Sep; 35():178-188. PubMed ID: 30100393 [TBL] [Abstract][Full Text] [Related]
15. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034 [TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer. Shibutani M; Maeda K; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M In Vivo; 2018; 32(1):151-158. PubMed ID: 29275313 [TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer. Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128 [TBL] [Abstract][Full Text] [Related]
18. Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma. Kinoshita F; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Tagawa T; Shimokawa M; Oda Y; Mori M Ann Surg Oncol; 2020 Jun; 27(6):2102-2109. PubMed ID: 31773516 [TBL] [Abstract][Full Text] [Related]
19. Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers. Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ Front Immunol; 2018; 9():2354. PubMed ID: 30369930 [TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy. Chen TW; Huang KC; Chiang SF; Chen WT; Ke TW; Chao KSC J Cancer Res Clin Oncol; 2019 Apr; 145(4):1043-1053. PubMed ID: 30874889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]